Dexlansoprazole: all 48 studies that test it
Page 1 of 1. Open to participants first (0), then studies with results posted, then the rest; newest registration first within each.
- A Study to Evaluate the Pharmacokinetics of Dexlansoprazole 30 Milligram (mg) and 60 mg Delayed-release Capsules in Healthy Chinese ParticipantsCompletedNCT03316976Phase 1Results posted
- Efficacy and Safety of Dexlansoprazole in Healing and Maintaining Healing of Erosive EsophagitisTerminatedNCT02873702Phase 3Results posted
- Efficacy and Safety of Dexlansoprazole on Heartburn Relief in Chinese PatientsCompletedNCT02873689Phase 3Results posted
- Dexlansoprazole in Asian Participants With Gastroesophageal Reflux DiseaseCompletedNCT02351960Phase 4Results posted
- Effect of Dexlansoprazole 60 mg QD and 60 mg BID on Recurrence of Intestinal Metaplasia in Subjects Who Have Achieved Complete Eradication of Barrett's Esophagus With Radiofrequency AblationTerminatedNCT02162758Phase 2Results posted
- Sensory Evaluation of Dexlansoprazole Delayed-Release Orally Disintegrating TabletsCompletedNCT02096458Phase 1Results posted
- Bioavailability, Safety, and Pharmacodynamics of Dexlansoprazole Delayed-Release Orally Disintegrating Tablets in Healthy ParticipantsCompletedNCT02064907Phase 1Results posted
- Safety and Efficacy of Dexlansoprazole Delayed-Release Capsules for Healing of Erosive Esophagitis and Maintenance of Healed Erosive Esophagitis and Relief of Heartburn in AdolescentsCompletedNCT01642615Phase 2Results posted
- Safety and Efficacy of Dexlansoprazole Delayed-Release Capsules in Treating Symptomatic Non-Erosive Gastroesophageal Reflux Disease in AdolescentsCompletedNCT01642602Phase 2Results posted
- The Effects of Dexlansoprazole for the Treatment of Throat-Related RefluxTerminatedNCT01317472Not applicableResults posted
- Effect of Dexlansoprazole on Bone HomeostasisCompletedNCT01216293Phase 1Results posted
- Does Intensive Acid Suppression Reduce Esophageal Inflammation and Recurrent Barrett's Esophagus Following Ablation?CompletedNCT01093755Phase 4Results posted
- Study to Evaluate the Pharmacokinetics and Safety of Dexlansoprazole in Pediatric Subjects With Symptomatic Gastroesophageal Reflux DiseaseCompletedNCT01045096Phase 1Results posted
- A Study of the Effects of Multiple Doses of Dexlansoprazole, Lansoprazole, Omeprazole or Esomeprazole on the Pharmacokinetics and Pharmacodynamics of Clopidogrel in Healthy Participants.CompletedNCT00942175Phase 1Results posted
- Efficacy of Dexlansoprazole MR on Heartburn Control in Participants Previously Receiving Twice Daily Proton Pump Inhibitor TherapyCompletedNCT00847808Phase 3Results posted
- Pharmacokinetic and Safety of Dexlansoprazole in Adolescents With Gastroesophageal Reflux DiseaseCompletedNCT00847210Phase 1Results posted
- A Study of Dexlansoprazole Modified Release Formulation to Treat Night HeartburnCompletedNCT00627016Phase 3Results posted
- Safety and Efficacy of Dexlansoprazole Modified Release Formulation to Treat Gastroesophageal Reflux DiseaseCompletedNCT00321984Phase 3Results posted
- Efficacy and Safety of Dexlansoprazole MR Compared to Placebo on Maintaining Healing in Subjects With Healed Erosive EsophagitisCompletedNCT00321737Phase 3Results posted
- Safety and Quality of Life Study of Dexlansoprazole Modified Release Formulation to Treat HeartburnCompletedNCT00255190Phase 3Results posted
- Efficacy and Safety of Dexlansoprazole MR on Maintaining Healing in Subjects With Healed Erosive EsophagitisCompletedNCT00255164Phase 3Results posted
- Comparison of Dexlansoprazole MR to Placebo on the Ability to Maintain Healing in Subjects With Healed Erosive EsophagitisCompletedNCT00255151Phase 3Results posted
- Safety and Efficacy of Dexlansoprazole Modified Release Formulation to Treat HeartburnCompletedNCT00251758Phase 3Results posted
- Efficacy and Safety of Dexlansoprazole Modified Release Formulation to Treat HeartburnCompletedNCT00251745Phase 3Results posted
- Efficacy and Safety of Dexlansoprazole MR and Lansoprazole on Healing of Erosive EsophagitisCompletedNCT00251719Phase 3Results posted
- Efficacy and Safety of Dexlansoprazole MR and Lansoprazole on Healing of Erosive EsophagitisCompletedNCT00251693Phase 3Results posted
- Therapeutic Effect of Vonoprazan Versus Dexlansoprazole in Treatment of Gastroesophageal Reflux DiseaseCompletedNCT06778395Phase 4
- Bioequivalence Study of DelanzoᵀᴹDR 60mg (Dexlansoprazole) Capsule With Dexilant® 60mg (Dexlansoprazole) Capsule in Healthy Pakistani Subjects.CompletedNCT04877834Phase 1
- Dexlansoprazole MR-Based Concomitant Quadruple TherapyCompletedNCT03829150Not applicable
- The Evaluation of Effectiveness Between Empirical and Guided Therapy for Unexplained Non-Cardiac Chest PainCompletedNCT03319121Phase 2/3
- Effectiveness of Physiologic Testing in PPI Non-RespondersCompletedNCT03202537Early Phase 1
- Comparing Clinical Efficacy of One-Week Dual Delayed-Release Dexlansoprazole and Esomeprazole for GERD Grade A and BCompletedNCT03128736Phase 4
- A Clinical Trial to Evaluate the Safety and Tolerability of Dexlansoprazole Injection in Healthy Chinese Adults（Part 2）Status unknownNCT03120273Phase 1
- Once Daily Dose Dexlansoprazole Quadruple Therapy for Helicobacter PyloriCompletedNCT03087162Phase 4
- An Open-Label Trial of Dexlansoprazole 60mg for the Relief of Heartburn During the Fasting Month of RamadanCompletedNCT03079050Phase 4
- A Clinical Trial to Evaluate the Safety and Tolerability of Dexlansoprazole Injection in Healthy Chinese Adults (Part 1)CompletedNCT03011125Phase 1
- Treatment Effect Between Dexlansoprazole and Double-dose Lansoprazole in Obesity Patients With Reflux EsophagitisStatus unknownNCT02759393Phase 4
- A Study to Check the Safety of Dexlansoprazole and Learn if it Can Treat Symptomatic Nonerosive Gastroesophageal Reflux Disease in Children 2 to 11 Years OldCompletedNCT02616302Phase 2
- A Study to Check the Safety of Dexlansoprazole and Learn If it Can Heal Erosive Esophagitis (EE) and Keep it Healed in Children 2 to 11 Years OldTerminatedNCT02615184Phase 2
- A Bioequivalence Study of Dexlansoprazole From Doxirazole 60 mg Capsules (Hikma Pharma,Egypt)and Dexilant 60 mg Delayed Release (DR) Capsules (Takeda Pharmaceuticals America Inc., USA)CompletedNCT02529787Phase 1
- Dexlansoprazole MR in Nonerosive Reflux DiseaseStatus unknownNCT02490449Not applicable
- Phase 1 Dexlansoprazole Delayed-Release Capsules for Acid-Related Disorders in Infants Aged 1 to 11 MonthsWithdrawnNCT02442752Phase 1
- Dexilant Treatment in Gastrointestinal Reflux Disease (GERD Related Non Cardiac Chest PainWithdrawnNCT01637571Phase 4
- Predictors of Proton Pump Inhibitor (PPI) Response in Eosinophilic EsophagitisWithdrawnNCT01479231Phase 1/2
- Dexlansoprazole to Treat Laryngopharyngeal Reflux and Lingual Tonsil HypertrophyStatus unknownNCT01328652Phase 4
- Evaluating Treatment Response in Laryngo-Pharyngeal RefluxWithdrawnNCT01328392Not applicable
- Can E-cadherin Found in Tissue/Blood be Valuable in Identifying & Monitoring Patients With Post-proton Pump Inhibitor (PPI)-Responsive HeartburnCompletedNCT01149395Phase 1
- Reflux Disease in Head and Neck Cancer Patients Undergoing Radiation TherapyWithdrawnNCT00928161Not applicable